| 1 | cost | 16,216 |
| 2 | approach/avoidance | 9 |
| 3 | abs-ei | 6 |
| 4 | 90.83 | 3 |
| 5 | anti-hallucinatory | 3 |
| 6 | biocover | 3 |
| 7 | effect= | 3 |
| 8 | purges | 3 |
| 9 | €900 | 3 |
| 10 | 0.00081 | 2 |
| 11 | 3.48- | 2 |
| 12 | 8-3 | 2 |
| 13 | 9,315 | 2 |
| 14 | bell/chsh | 2 |
| 15 | costs/higher | 2 |
| 16 | dose-omission | 2 |
| 17 | ecrt | 2 |
| 18 | exposure-mortality | 2 |
| 19 | mgds | 2 |
| 20 | micro-arousals | 2 |
| 21 | plaque-reducing | 2 |
| 22 | pound42,500 | 2 |
| 23 | study-year | 2 |
| 24 | urediniospores | 2 |
| 25 | vital-band | 2 |
| 26 | £1,936 | 2 |
| 27 | £2 | 2 |
| 28 | €187 | 2 |
| 29 | 'programmatic | 1 |
| 30 | -7453 | 1 |
| 31 | -dm81,900 | 1 |
| 32 | -healthcare | 1 |
| 33 | .comparative | 1 |
| 34 | 0-912 | 1 |
| 35 | 0.06+/-0.22 | 1 |
| 36 | 0.086±0.008g | 1 |
| 37 | 0.089±0.004g | 1 |
| 38 | 0.12-1.69 | 1 |
| 39 | 0.13+/-0.05 | 1 |
| 40 | 0.93+/-0.14 | 1 |
| 41 | 1,047+/-276 | 1 |
| 42 | 1.00-1.43 | 1 |
| 43 | 1.10-5.21 | 1 |
| 44 | 1.14-2.79 | 1 |
| 45 | 1.15-3.90 | 1 |
| 46 | 1.18-1.63 | 1 |
| 47 | 1.23-3.89 | 1 |
| 48 | 1.28g/kg | 1 |
| 49 | 1.35-1.81 | 1 |
| 50 | 1.40-5.21 | 1 |
| 51 | 1.55m | 1 |
| 52 | 1.62-2.30 | 1 |
| 53 | 1.64ml/kg | 1 |
| 54 | 1.75-mg/kg | 1 |
| 55 | 11.78+/-3.26 | 1 |
| 56 | 11203euro | 1 |
| 57 | 123,761 | 1 |
| 58 | 184.63 | 1 |
| 59 | 2.0-mg/kg | 1 |
| 60 | 2.0-microg/kg | 1 |
| 61 | 2.03-9.74 | 1 |
| 62 | 2.83ml/kg | 1 |
| 63 | 202.43 | 1 |
| 64 | 222-381 | 1 |
| 65 | 26147 | 1 |
| 66 | 2·2-86 | 1 |
| 67 | 3,855.50€/us | 1 |
| 68 | 3.03-5.59 | 1 |
| 69 | 3.5-49 | 1 |
| 70 | 36270euro | 1 |
| 71 | 4-beats | 1 |
| 72 | 4.2h | 1 |
| 73 | 4.3g/d | 1 |
| 74 | 40,9 | 1 |
| 75 | 415-528 | 1 |
| 76 | 5,450 | 1 |
| 77 | 5,789-6,360 | 1 |
| 78 | 50,5 | 1 |
| 79 | 601.5 | 1 |
| 80 | 65·7 | 1 |
| 81 | 69·4 | 1 |
| 82 | 795.57 | 1 |
| 83 | 8.2g/d | 1 |
| 84 | 85-3 | 1 |
| 85 | 9.34+/-4.41 | 1 |
| 86 | 90-5 | 1 |
| 87 | agents/pharmacological | 1 |
| 88 | already-included | 1 |
| 89 | anti-conceptive | 1 |
| 90 | calendar-year | 1 |
| 91 | caries-arresting | 1 |
| 92 | changes/emerging | 1 |
| 93 | claystone | 1 |
| 94 | comparitive | 1 |
| 95 | conut´s | 1 |
| 96 | cost/incremental | 1 |
| 97 | d94,600 | 1 |
| 98 | drb1*14:01g | 1 |
| 99 | dsc-18 | 1 |
| 100 | euro15,000 | 1 |
| 101 | euro410 | 1 |
| 102 | euro50,900 | 1 |
| 103 | euro684 | 1 |
| 104 | euro7865 | 1 |
| 105 | gerontocratic | 1 |
| 106 | increased.research | 1 |
| 107 | ir=0.63 | 1 |
| 108 | knowledge-behavior | 1 |
| 109 | kong'äìspecific | 1 |
| 110 | multiannual | 1 |
| 111 | mycophobic | 1 |
| 112 | nanogramme | 1 |
| 113 | networking/referral | 1 |
| 114 | non-environmental | 1 |
| 115 | nought | 1 |
| 116 | osms | 1 |
| 117 | phenotype-associated | 1 |
| 118 | physician-prescribing | 1 |
| 119 | placebo-agomelatine | 1 |
| 120 | polimicrobial | 1 |
| 121 | pound24,000 | 1 |
| 122 | pound2847 | 1 |
| 123 | pound43 | 1 |
| 124 | pound5332 | 1 |
| 125 | pound9 | 1 |
| 126 | pre-syncopes | 1 |
| 127 | preparations.contraceptive | 1 |
| 128 | racial/socioeconomic | 1 |
| 129 | radiographic/clinical | 1 |
| 130 | stress/discomfort | 1 |
| 131 | sub-nanogram | 1 |
| 132 | treefall | 1 |
| 133 | urine-testing | 1 |
| 134 | use.clinical | 1 |
| 135 | who-pb-mdt=0.35 | 1 |
| 136 | £0.33 | 1 |
| 137 | £1,274,000 | 1 |
| 138 | £1,355 | 1 |
| 139 | £1,461 | 1 |
| 140 | £1,896 | 1 |
| 141 | £12,700 | 1 |
| 142 | £12.60 | 1 |
| 143 | £13,558 | 1 |
| 144 | £13,751 | 1 |
| 145 | £15,300 | 1 |
| 146 | £150,000 | 1 |
| 147 | £17,075 | 1 |
| 148 | £20,493 | 1 |
| 149 | £27,899 | 1 |
| 150 | £33,851 | 1 |
| 151 | £4.44 | 1 |
| 152 | £40,020 | 1 |
| 153 | £43,900 | 1 |
| 154 | £450,000 | 1 |
| 155 | £4923 | 1 |
| 156 | £511,351 | 1 |
| 157 | £591 | 1 |
| 158 | £6398 | 1 |
| 159 | £7,721 | 1 |
| 160 | £7196 | 1 |
| 161 | £8092 | 1 |
| 162 | £9316 | 1 |
| 163 | £970 | 1 |
| 164 | £98,000 | 1 |
| 165 | €1,852 | 1 |
| 166 | €1.29 | 1 |
| 167 | €13,743 | 1 |
| 168 | €1375 | 1 |
| 169 | €14,296 | 1 |
| 170 | €14,710 | 1 |
| 171 | €14.91 | 1 |
| 172 | €15,155 | 1 |
| 173 | €1762 | 1 |
| 174 | €19,371 | 1 |
| 175 | €19,457 | 1 |
| 176 | €2069 | 1 |
| 177 | €24,697 | 1 |
| 178 | €25.00 | 1 |
| 179 | €25.61 | 1 |
| 180 | €258 | 1 |
| 181 | €276 | 1 |
| 182 | €29,872 | 1 |
| 183 | €3,800 | 1 |
| 184 | €31,616 | 1 |
| 185 | €37.58 | 1 |
| 186 | €37.78 | 1 |
| 187 | €44,350 | 1 |
| 188 | €440.2 | 1 |
| 189 | €4897 | 1 |
| 190 | €5,630 | 1 |
| 191 | €5532 | 1 |
| 192 | €67,361 | 1 |
| 193 | €7,300 | 1 |
| 194 | €7106 | 1 |
| 195 | €73,359 | 1 |
| 196 | €751 | 1 |
| 197 | €9,872 | 1 |
| 1 | 'programmatic | 1 |
| 2 | -7453 | 1 |
| 3 | -dm81,900 | 1 |
| 4 | -healthcare | 1 |
| 5 | .comparative | 1 |
| 6 | 0-912 | 1 |
| 7 | 0.00081 | 2 |
| 8 | 0.06+/-0.22 | 1 |
| 9 | 0.086±0.008g | 1 |
| 10 | 0.089±0.004g | 1 |
| 11 | 0.12-1.69 | 1 |
| 12 | 0.13+/-0.05 | 1 |
| 13 | 0.93+/-0.14 | 1 |
| 14 | 1,047+/-276 | 1 |
| 15 | 1.00-1.43 | 1 |
| 16 | 1.10-5.21 | 1 |
| 17 | 1.14-2.79 | 1 |
| 18 | 1.15-3.90 | 1 |
| 19 | 1.18-1.63 | 1 |
| 20 | 1.23-3.89 | 1 |
| 21 | 1.28g/kg | 1 |
| 22 | 1.35-1.81 | 1 |
| 23 | 1.40-5.21 | 1 |
| 24 | 1.55m | 1 |
| 25 | 1.62-2.30 | 1 |
| 26 | 1.64ml/kg | 1 |
| 27 | 1.75-mg/kg | 1 |
| 28 | 11.78+/-3.26 | 1 |
| 29 | 11203euro | 1 |
| 30 | 123,761 | 1 |
| 31 | 184.63 | 1 |
| 32 | 2.0-mg/kg | 1 |
| 33 | 2.0-microg/kg | 1 |
| 34 | 2.03-9.74 | 1 |
| 35 | 2.83ml/kg | 1 |
| 36 | 202.43 | 1 |
| 37 | 222-381 | 1 |
| 38 | 26147 | 1 |
| 39 | 2·2-86 | 1 |
| 40 | 3,855.50€/us | 1 |
| 41 | 3.03-5.59 | 1 |
| 42 | 3.48- | 2 |
| 43 | 3.5-49 | 1 |
| 44 | 36270euro | 1 |
| 45 | 4-beats | 1 |
| 46 | 4.2h | 1 |
| 47 | 4.3g/d | 1 |
| 48 | 40,9 | 1 |
| 49 | 415-528 | 1 |
| 50 | 5,450 | 1 |
| 51 | 5,789-6,360 | 1 |
| 52 | 50,5 | 1 |
| 53 | 601.5 | 1 |
| 54 | 65·7 | 1 |
| 55 | 69·4 | 1 |
| 56 | 795.57 | 1 |
| 57 | 8-3 | 2 |
| 58 | 8.2g/d | 1 |
| 59 | 85-3 | 1 |
| 60 | 9,315 | 2 |
| 61 | 9.34+/-4.41 | 1 |
| 62 | 90-5 | 1 |
| 63 | 90.83 | 3 |
| 64 | abs-ei | 6 |
| 65 | agents/pharmacological | 1 |
| 66 | already-included | 1 |
| 67 | anti-conceptive | 1 |
| 68 | anti-hallucinatory | 3 |
| 69 | approach/avoidance | 9 |
| 70 | bell/chsh | 2 |
| 71 | biocover | 3 |
| 72 | calendar-year | 1 |
| 73 | caries-arresting | 1 |
| 74 | changes/emerging | 1 |
| 75 | claystone | 1 |
| 76 | comparitive | 1 |
| 77 | conut´s | 1 |
| 78 | cost | 16,216 |
| 79 | cost/incremental | 1 |
| 80 | costs/higher | 2 |
| 81 | d94,600 | 1 |
| 82 | dose-omission | 2 |
| 83 | drb1*14:01g | 1 |
| 84 | dsc-18 | 1 |
| 85 | ecrt | 2 |
| 86 | effect= | 3 |
| 87 | euro15,000 | 1 |
| 88 | euro410 | 1 |
| 89 | euro50,900 | 1 |
| 90 | euro684 | 1 |
| 91 | euro7865 | 1 |
| 92 | exposure-mortality | 2 |
| 93 | gerontocratic | 1 |
| 94 | increased.research | 1 |
| 95 | ir=0.63 | 1 |
| 96 | knowledge-behavior | 1 |
| 97 | kong'äìspecific | 1 |
| 98 | mgds | 2 |
| 99 | micro-arousals | 2 |
| 100 | multiannual | 1 |
| 101 | mycophobic | 1 |
| 102 | nanogramme | 1 |
| 103 | networking/referral | 1 |
| 104 | non-environmental | 1 |
| 105 | nought | 1 |
| 106 | osms | 1 |
| 107 | phenotype-associated | 1 |
| 108 | physician-prescribing | 1 |
| 109 | placebo-agomelatine | 1 |
| 110 | plaque-reducing | 2 |
| 111 | polimicrobial | 1 |
| 112 | pound24,000 | 1 |
| 113 | pound2847 | 1 |
| 114 | pound42,500 | 2 |
| 115 | pound43 | 1 |
| 116 | pound5332 | 1 |
| 117 | pound9 | 1 |
| 118 | pre-syncopes | 1 |
| 119 | preparations.contraceptive | 1 |
| 120 | purges | 3 |
| 121 | racial/socioeconomic | 1 |
| 122 | radiographic/clinical | 1 |
| 123 | stress/discomfort | 1 |
| 124 | study-year | 2 |
| 125 | sub-nanogram | 1 |
| 126 | treefall | 1 |
| 127 | urediniospores | 2 |
| 128 | urine-testing | 1 |
| 129 | use.clinical | 1 |
| 130 | vital-band | 2 |
| 131 | who-pb-mdt=0.35 | 1 |
| 132 | £0.33 | 1 |
| 133 | £1,274,000 | 1 |
| 134 | £1,355 | 1 |
| 135 | £1,461 | 1 |
| 136 | £1,896 | 1 |
| 137 | £1,936 | 2 |
| 138 | £12,700 | 1 |
| 139 | £12.60 | 1 |
| 140 | £13,558 | 1 |
| 141 | £13,751 | 1 |
| 142 | £15,300 | 1 |
| 143 | £150,000 | 1 |
| 144 | £17,075 | 1 |
| 145 | £2 | 2 |
| 146 | £20,493 | 1 |
| 147 | £27,899 | 1 |
| 148 | £33,851 | 1 |
| 149 | £4.44 | 1 |
| 150 | £40,020 | 1 |
| 151 | £43,900 | 1 |
| 152 | £450,000 | 1 |
| 153 | £4923 | 1 |
| 154 | £511,351 | 1 |
| 155 | £591 | 1 |
| 156 | £6398 | 1 |
| 157 | £7,721 | 1 |
| 158 | £7196 | 1 |
| 159 | £8092 | 1 |
| 160 | £9316 | 1 |
| 161 | £970 | 1 |
| 162 | £98,000 | 1 |
| 163 | €1,852 | 1 |
| 164 | €1.29 | 1 |
| 165 | €13,743 | 1 |
| 166 | €1375 | 1 |
| 167 | €14,296 | 1 |
| 168 | €14,710 | 1 |
| 169 | €14.91 | 1 |
| 170 | €15,155 | 1 |
| 171 | €1762 | 1 |
| 172 | €187 | 2 |
| 173 | €19,371 | 1 |
| 174 | €19,457 | 1 |
| 175 | €2069 | 1 |
| 176 | €24,697 | 1 |
| 177 | €25.00 | 1 |
| 178 | €25.61 | 1 |
| 179 | €258 | 1 |
| 180 | €276 | 1 |
| 181 | €29,872 | 1 |
| 182 | €3,800 | 1 |
| 183 | €31,616 | 1 |
| 184 | €37.58 | 1 |
| 185 | €37.78 | 1 |
| 186 | €44,350 | 1 |
| 187 | €440.2 | 1 |
| 188 | €4897 | 1 |
| 189 | €5,630 | 1 |
| 190 | €5532 | 1 |
| 191 | €67,361 | 1 |
| 192 | €7,300 | 1 |
| 193 | €7106 | 1 |
| 194 | €73,359 | 1 |
| 195 | €751 | 1 |
| 196 | €9,872 | 1 |
| 197 | €900 | 3 |
| 1 | 3.48- | 2 |
| 2 | €25.00 | 1 |
| 3 | £150,000 | 1 |
| 4 | £450,000 | 1 |
| 5 | pound24,000 | 1 |
| 6 | £1,274,000 | 1 |
| 7 | euro15,000 | 1 |
| 8 | £98,000 | 1 |
| 9 | £15,300 | 1 |
| 10 | €7,300 | 1 |
| 11 | pound42,500 | 2 |
| 12 | d94,600 | 1 |
| 13 | £12,700 | 1 |
| 14 | €3,800 | 1 |
| 15 | euro50,900 | 1 |
| 16 | -dm81,900 | 1 |
| 17 | £43,900 | 1 |
| 18 | €900 | 3 |
| 19 | euro410 | 1 |
| 20 | €14,710 | 1 |
| 21 | £40,020 | 1 |
| 22 | 1.62-2.30 | 1 |
| 23 | €5,630 | 1 |
| 24 | €44,350 | 1 |
| 25 | 5,450 | 1 |
| 26 | £12.60 | 1 |
| 27 | 5,789-6,360 | 1 |
| 28 | £970 | 1 |
| 29 | 1.15-3.90 | 1 |
| 30 | 1.10-5.21 | 1 |
| 31 | 1.40-5.21 | 1 |
| 32 | £7,721 | 1 |
| 33 | 9.34+/-4.41 | 1 |
| 34 | £511,351 | 1 |
| 35 | £13,751 | 1 |
| 36 | €751 | 1 |
| 37 | £33,851 | 1 |
| 38 | €25.61 | 1 |
| 39 | €67,361 | 1 |
| 40 | £1,461 | 1 |
| 41 | 123,761 | 1 |
| 42 | €19,371 | 1 |
| 43 | 1.35-1.81 | 1 |
| 44 | 0.00081 | 2 |
| 45 | 222-381 | 1 |
| 46 | €14.91 | 1 |
| 47 | £591 | 1 |
| 48 | €440.2 | 1 |
| 49 | 0-912 | 1 |
| 50 | 0.06+/-0.22 | 1 |
| 51 | pound5332 | 1 |
| 52 | €5532 | 1 |
| 53 | €1,852 | 1 |
| 54 | €1762 | 1 |
| 55 | €29,872 | 1 |
| 56 | €9,872 | 1 |
| 57 | £8092 | 1 |
| 58 | £2 | 2 |
| 59 | 85-3 | 1 |
| 60 | 8-3 | 2 |
| 61 | £4923 | 1 |
| 62 | £0.33 | 1 |
| 63 | 1.00-1.43 | 1 |
| 64 | 202.43 | 1 |
| 65 | €13,743 | 1 |
| 66 | pound43 | 1 |
| 67 | -7453 | 1 |
| 68 | ir=0.63 | 1 |
| 69 | 1.18-1.63 | 1 |
| 70 | 184.63 | 1 |
| 71 | 90.83 | 3 |
| 72 | £20,493 | 1 |
| 73 | 0.93+/-0.14 | 1 |
| 74 | £4.44 | 1 |
| 75 | 2.03-9.74 | 1 |
| 76 | euro684 | 1 |
| 77 | 69·4 | 1 |
| 78 | 50,5 | 1 |
| 79 | 90-5 | 1 |
| 80 | 601.5 | 1 |
| 81 | 0.13+/-0.05 | 1 |
| 82 | 9,315 | 2 |
| 83 | who-pb-mdt=0.35 | 1 |
| 84 | €15,155 | 1 |
| 85 | £1,355 | 1 |
| 86 | euro7865 | 1 |
| 87 | £17,075 | 1 |
| 88 | €1375 | 1 |
| 89 | €7106 | 1 |
| 90 | £9316 | 1 |
| 91 | €31,616 | 1 |
| 92 | 11.78+/-3.26 | 1 |
| 93 | £1,936 | 2 |
| 94 | 1,047+/-276 | 1 |
| 95 | €276 | 1 |
| 96 | 2·2-86 | 1 |
| 97 | £7196 | 1 |
| 98 | €14,296 | 1 |
| 99 | £1,896 | 1 |
| 100 | 26147 | 1 |
| 101 | pound2847 | 1 |
| 102 | 795.57 | 1 |
| 103 | €19,457 | 1 |
| 104 | €187 | 2 |
| 105 | €24,697 | 1 |
| 106 | €4897 | 1 |
| 107 | 65·7 | 1 |
| 108 | dsc-18 | 1 |
| 109 | 415-528 | 1 |
| 110 | €37.58 | 1 |
| 111 | €258 | 1 |
| 112 | £13,558 | 1 |
| 113 | €37.78 | 1 |
| 114 | £6398 | 1 |
| 115 | 40,9 | 1 |
| 116 | €1.29 | 1 |
| 117 | 3.5-49 | 1 |
| 118 | 3.03-5.59 | 1 |
| 119 | €73,359 | 1 |
| 120 | 0.12-1.69 | 1 |
| 121 | €2069 | 1 |
| 122 | 1.14-2.79 | 1 |
| 123 | 1.23-3.89 | 1 |
| 124 | £27,899 | 1 |
| 125 | pound9 | 1 |
| 126 | effect= | 3 |
| 127 | mycophobic | 1 |
| 128 | kong'äìspecific | 1 |
| 129 | racial/socioeconomic | 1 |
| 130 | 'programmatic | 1 |
| 131 | gerontocratic | 1 |
| 132 | 8.2g/d | 1 |
| 133 | 4.3g/d | 1 |
| 134 | already-included | 1 |
| 135 | phenotype-associated | 1 |
| 136 | vital-band | 2 |
| 137 | approach/avoidance | 9 |
| 138 | nanogramme | 1 |
| 139 | placebo-agomelatine | 1 |
| 140 | claystone | 1 |
| 141 | -healthcare | 1 |
| 142 | .comparative | 1 |
| 143 | comparitive | 1 |
| 144 | preparations.contraceptive | 1 |
| 145 | anti-conceptive | 1 |
| 146 | drb1*14:01g | 1 |
| 147 | 0.089±0.004g | 1 |
| 148 | 0.086±0.008g | 1 |
| 149 | 1.28g/kg | 1 |
| 150 | 2.0-mg/kg | 1 |
| 151 | 1.75-mg/kg | 1 |
| 152 | 2.0-microg/kg | 1 |
| 153 | 2.83ml/kg | 1 |
| 154 | 1.64ml/kg | 1 |
| 155 | physician-prescribing | 1 |
| 156 | plaque-reducing | 2 |
| 157 | changes/emerging | 1 |
| 158 | caries-arresting | 1 |
| 159 | urine-testing | 1 |
| 160 | 4.2h | 1 |
| 161 | increased.research | 1 |
| 162 | bell/chsh | 2 |
| 163 | abs-ei | 6 |
| 164 | agents/pharmacological | 1 |
| 165 | use.clinical | 1 |
| 166 | radiographic/clinical | 1 |
| 167 | polimicrobial | 1 |
| 168 | networking/referral | 1 |
| 169 | cost/incremental | 1 |
| 170 | non-environmental | 1 |
| 171 | multiannual | 1 |
| 172 | treefall | 1 |
| 173 | 1.55m | 1 |
| 174 | sub-nanogram | 1 |
| 175 | dose-omission | 2 |
| 176 | 36270euro | 1 |
| 177 | 11203euro | 1 |
| 178 | calendar-year | 1 |
| 179 | study-year | 2 |
| 180 | costs/higher | 2 |
| 181 | biocover | 3 |
| 182 | knowledge-behavior | 1 |
| 183 | mgds | 2 |
| 184 | purges | 3 |
| 185 | pre-syncopes | 1 |
| 186 | urediniospores | 2 |
| 187 | micro-arousals | 2 |
| 188 | osms | 1 |
| 189 | 4-beats | 1 |
| 190 | 3,855.50€/us | 1 |
| 191 | conut´s | 1 |
| 192 | nought | 1 |
| 193 | ecrt | 2 |
| 194 | stress/discomfort | 1 |
| 195 | cost | 16,216 |
| 196 | anti-hallucinatory | 3 |
| 197 | exposure-mortality | 2 |